BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16616242)

  • 1. Reconstitution of CD39 in liposomes amplifies nucleoside triphosphate diphosphohydrolase activity and restores thromboregulatory properties.
    Haller CA; Cui W; Wen J; Robson SC; Chaikof EL
    J Vasc Surg; 2006 Apr; 43(4):816-23. PubMed ID: 16616242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
    Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
    Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Pinsky DJ; Sesti C; Levi R
    J Pharmacol Exp Ther; 2003 Apr; 305(1):9-16. PubMed ID: 12649347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39.
    Gayle RB; Maliszewski CR; Gimpel SD; Schoenborn MA; Caspary RG; Richards C; Brasel K; Price V; Drosopoulos JH; Islam N; Alyonycheva TN; Broekman MJ; Marcus AJ
    J Clin Invest; 1998 May; 101(9):1851-9. PubMed ID: 9576748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Pinsky DJ; Islam N; Maliszewsk CR
    Ital Heart J; 2001 Nov; 2(11):824-30. PubMed ID: 11770867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Alyonycheva TN; Safier LB; Hajjar KA; Posnett DN; Schoenborn MA; Schooley KA; Gayle RB; Maliszewski CR
    J Clin Invest; 1997 Mar; 99(6):1351-60. PubMed ID: 9077545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of extracellular ATP metabolism in regulation of platelet reactivity.
    Birk AV; Broekman MJ; Gladek EM; Robertson HD; Drosopoulos JH; Marcus AJ; Szeto HH
    J Lab Clin Med; 2002 Sep; 140(3):166-75. PubMed ID: 12271274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
    Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Olson KE; Islam N; Pinsky DJ; Levi R
    Semin Thromb Hemost; 2005 Apr; 31(2):234-46. PubMed ID: 15852226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nucleoside triphosphate diphosphohydrolase-1/CD39 is incorporated into human immunodeficiency type 1 particles, where it remains biologically active.
    Barat C; Martin G; Beaudoin AR; Sévigny J; Tremblay MJ
    J Mol Biol; 2007 Aug; 371(1):269-82. PubMed ID: 17560607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in anti-platelet therapies: potential use of CD39/vascular ATP diphosphohydrolase in thrombotic disorders.
    Qawi I; Robson SC
    Curr Drug Targets; 2000 Nov; 1(3):285-96. PubMed ID: 11465076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.
    Degen H; Borst O; Ziegler M; Mojica Munoz AK; Jamasbi J; Walker B; Göbel S; Fassbender J; Adler K; Brandl R; Münch G; Lorenz R; Siess W; Gawaz M; Ungerer M
    J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of SolCD39, a novel inhibitor of Platelet Aggregation, on Platelet Deposition and Aggregation after PTCA in a Porcine Model.
    Buergler JM; Maliszewski CR; Broekman MJ; Kaluza GL; Schulz DG; Marcus AJ; Raizner AE; Kleiman NS; Ali NM
    J Thromb Thrombolysis; 2005 Apr; 19(2):115-22. PubMed ID: 16052302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection.
    Imai M; Takigami K; Guckelberger O; Enjyoji K; Smith RN; Lin Y; Csizmadia E; Sévigny J; Rosenberg RD; Bach FH; Robson SC
    Mol Med; 1999 Nov; 5(11):743-52. PubMed ID: 10656876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39.
    Hyman MC; Petrovic-Djergovic D; Visovatti SH; Liao H; Yanamadala S; Bouïs D; Su EJ; Lawrence DA; Broekman MJ; Marcus AJ; Pinsky DJ
    J Clin Invest; 2009 May; 119(5):1136-49. PubMed ID: 19381014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury.
    Köhler D; Eckle T; Faigle M; Grenz A; Mittelbronn M; Laucher S; Hart ML; Robson SC; Müller CE; Eltzschig HK
    Circulation; 2007 Oct; 116(16):1784-94. PubMed ID: 17909107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmembrane domains confer different substrate specificities and adenosine diphosphate hydrolysis mechanisms on CD39, CD39L1, and chimeras.
    Grinthal A; Guidotti G
    Biochemistry; 2002 Feb; 41(6):1947-56. PubMed ID: 11827541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation.
    Dwyer KM; Robson SC; Nandurkar HH; Campbell DJ; Gock H; Murray-Segal LJ; Fisicaro N; Mysore TB; Kaczmarek E; Cowan PJ; d'Apice AJ
    J Clin Invest; 2004 May; 113(10):1440-6. PubMed ID: 15146241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered E-NTPDase/E-ADA activities and CD39 expression in platelets of sickle cell anemia patients.
    Castilhos LG; Doleski PH; Adefegha SA; Becker LV; Ruchel JB; Leal DB
    Biomed Pharmacother; 2016 Apr; 79():241-6. PubMed ID: 27044834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of thrombin-induced deactivation of CD39/ATPDase in endothelial cells by HMG-CoA reductase inhibition: effects on Rho-GTPase and adenosine nucleotide metabolism.
    Kaneider NC; Egger P; Dunzendorfer S; Noris P; Balduini CL; Gritti D; Ricevuti G; Wiedermann CJ
    Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):894-900. PubMed ID: 12067895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.